Orexo extends patent protection for its nasal epinephrine powder product OX640 in the US
The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
The campaign marks an important milestone in its journey within the pharmaceutical manufacturing industry
Around 7% of the Indian population suffers from IBS
NM5072 is an anti-Properdin antibody that selectively blocks the alternative pathway while maintaining the integrity of the classical pathway required for fending off infections
The demand in Africa for COVID-19 vaccines has declined
This facility manufactures APIs & formulations of oncology and non-oncology products.
Highly effective preservation solutions ensuring the safety and protection of personal care products
The approval marks a significant milestone for the American pharmaceutical company in the field of UC
Subscribe To Our Newsletter & Stay Updated